DIFFERENTIAL-EFFECTS OF GLUTATHIONE DEPLETION ON T-CELL SUBSETS

被引:67
作者
GMUNDER, H
DROGE, W
机构
[1] Division of Immunochemistry, Institute of Immunology and Genetics, German Cancer Research Center, D-6900 Heidelberg
关键词
D O I
10.1016/0008-8749(91)90147-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glutathione (GSH) is known to play an important role in various lymphocyte functions. We now report that different T cell subsets express different requirements for intracellular GSH. Depletion of intracellular GSH by buthionine sulfoximine (BSO), a specific inhibitor of GSH biosynthesis, decreases the proportion of CD8+ cells (i.e., increases the CD4+ CD8+ ratio), and inhibits particularly the generation of large blast-like CD8+ cells and cytotoxic T lymphocyte (CTL) activity. CTL activity is restored by administration of exogenous GSH. Differential effects of GSH depletion were also seen at the level of individual T cell clones. The CD4+ helper T cell clone D10.G4.1.HD was found to express a high rate of interleukin 2 (IL-2) dependent DNA synthesis even after severe depletion of intracellular GSH, whereas other T cell clones including the clone 29 were severely inhibited by BSO. The results of these studies suggest that the decreased intracellular GSH levels of HIV-1 seropositive persons are probably not (directly) responsible for the selective depletion of the CD4+ T cell subset but may be responsible for a cellular dysfunction of the CD8+ subset and for the ultimate failure of the CTL to control the viral infection in these patients. © 1991.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 36 条
  • [1] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [2] BEVAN MJ, 1975, J IMMUNOL, V114, P559
  • [3] PERIPHERAL-BLOOD MONONUCLEAR CELL ABNORMALITIES AND THEIR RELATIONSHIP TO CLINICAL COURSE IN HOMOSEXUAL MEN WITH HIV INFECTION
    DEMARTINI, RM
    TURNER, RR
    FORMENTI, SC
    BOONE, DC
    BISHOP, PC
    LEVINE, AM
    PARKER, JW
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 46 (02): : 258 - 271
  • [4] DEPAOLI P, 1988, CLIN EXP IMMUNOL, V74, P317
  • [5] DROGE W, 1984, J IMMUNOL, V132, P2749
  • [6] LOW CONCENTRATIONS OF ACID-SOLUBLE THIOL (CYSTEINE) IN THE BLOOD-PLASMA OF HIV-1-INFECTED PATIENTS
    ECK, HP
    GMUNDER, H
    HARTMANN, M
    PETZOLDT, D
    DANIEL, V
    DROGE, W
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1989, 370 (02): : 101 - 108
  • [7] QUANTITATIVE CHANGES IN T-HELPER OR T-SUPPRESSOR CYTO-TOXIC LYMPHOCYTE SUBSETS THAT DISTINGUISH ACQUIRED IMMUNE-DEFICIENCY SYNDROME FROM OTHER IMMUNE SUBSET DISORDERS
    FAHEY, JL
    PRINCE, H
    WEAVER, M
    GROOPMAN, J
    VISSCHER, B
    SCHWARTZ, K
    DETELS, R
    [J]. AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) : 95 - 100
  • [8] FALK W, 1983, J IMMUNOL, V130, P2214
  • [9] FANGER MW, 1970, J IMMUNOL, V105, P1043
  • [10] ENHANCEMENT OF INTRACELLULAR GLUTATHIONE PROMOTES LYMPHOCYTE-ACTIVATION BY MITOGEN
    FIDELUS, RK
    TSAN, MF
    [J]. CELLULAR IMMUNOLOGY, 1986, 97 (01) : 155 - 163